✦ LIBER ✦

Interferon-α (IFN) induction dosing and ribavirin (R) in IFN non-responders (NR) with chronic hepatitis C (CHC): Interim analysis of an ongoing study (SASL 10)

✍ Scribed by E.C. Renner-Schneiter; J-F. Dufour; R. Fried; J.J. Gonvers; M. Knoblauch; P.J. Malè; F. Negro; J. Reichen; C. Rohner; M. Steuerwald; E.L. Renner

Book ID: 119526065
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 153 KB
Volume: 32
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(00)80730-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Controlled study of interferon A-2B (IFN

Controlled study of interferon A-2B (IFN) plus ribavirin (RIB) in patients with chronic hepatitis C (CHC) ‘non-responders’ to IFN

✍ R. Moreno-Otero 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 319 KB

A combined therapy with high dose of int

A combined therapy with high dose of interferon (IFN)-alpha as an induction and ribavirin in non-responders to IFN alone with chronic hepatitis C

✍ Takashimizu, Shinji; Watanabe, Norihito; Mine, Tetsuya; Matsuzaki, Shohei 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Virologic response in re-treatment of ch

Virologic response in re-treatment of chronic hepatitis C interferon (IFN) virologic non-responders (NR) and responder-relapsers (RR): IFN induction followed by combination ribavirin: High dose IFN (780 MIU/52 weeks)

✍ Pimstone, Neville R.; Canio, John B.; Powell, Jerry S.; Kokosinski, Janet; Saich 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 187 KB

High dose of interferonα (IFN) plus riba

High dose of interferonα (IFN) plus ribavirin (RIBA) for 6 or 12 months in non responder (NR) patients with chronic hepatitis C (CHC): Results of a randomized trial

✍ P. Andreone; C. Cursaro; A. Gramenzi; M. Margotti; E. Ferri; S. Talarico; L. Di 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Re-treatment virologic response in chron

Re-treatment virologic response in chronic hepatitis C virologic non-responders (NR) and responder-relapsers (NR) to interferon (IFN) monotherapy: IFN α-2b induction followed by combination ribavirin/interferon α-2b vs combination ribavirin/interferon α-2b (780 MIU/52 weeks rebetron therapy)

✍ Pimstone, Neville R.; Canio, John B.; Chiang, Michelle H.; Kokosinski, Janet; Po 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Race as a predictor for sustained virolo

Race as a predictor for sustained virological response in IFN non-responders with chronic hepatitis C: Results of a randomized, placebo-controlled study with high induction dose IFN-α2b+ribavirin

✍ Hari S. Conjeevaram; Daniel Ganger; Thelma E. Wiley; Steven Flamm; Kenneth O'Rio 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 177 KB